Learn more about how Access hsTnI provides reliable, rapid test results that physicians can count on to aid in appropriate patient treatment.

High-sensitivity Troponin I: Opportunities in Emergency Care

Access hsTnI demonstrates <10% CV at all 99th percentile cutoffs and detects >99% of values for both men and women.1 It provides reliable, rapid test results that physicians can count on to support appropriate patient treatment.

Register to learn more.

Part 1: Definition of a High-sensitivity Assay
Part 2: Opportunities in Emergency Care
Part 3: Implementation of High-sensitivity Assays into Clinical Care

Presenter: Professor Louise Cullen

Professor Cullen is a preeminent staff specialist in emergency medicine, a clinical trialist and outcomes researcher in acute diseases. She is enthusiastically involved in the translation of research by clinical redesign and innovation. As an accomplished acute-disease researcher, Professor Cullen has focused on the diagnosis and management of patients presenting with possible acute coronary syndromes (ACS) in the emergency department (ED). She has been engaged in many international collaborations (including ASPECT, ADAPT and APACE studies). She has authored over 100 publications in peer-reviewed journals including The Lancet, focused on strategies to improve efficiency, while maintaining safety for patients with possible ACS, syncope, heart failure, shortness of breath and atrial fibrillation. Professor Cullen’s mantra is that “you do not do research for research sake,” and, as such, clinical redesign and translational research is a key part of her endeavor.